| Abstract: | There is an unmet medical need for radiation countermeasures that can be deployed for treatment of exposed individuals during ionizing radiation (IR) accidents or terrorism. Wharton's jelly mesenchymal stem cells (WJ‐MSCs) from human umbilical cord have been shown to avoid allorecognition and induce a tissue‐regenerating microenvironment, which makes them an attractive candidate for mitigating IR injury. We found that WJ‐MSCs protected mice from a lethal dose of IR even when transplanted up to 24 hours after irradiation, and a combination of WJ‐MSCs and antibiotic (tetracycline) could further expand the window of protection offered by WJ‐MSCs. This combinatorial approach mitigated IR‐induced damage to the hematopoietic and gastrointestinal system. WJ‐MSCs increased the serum concentration of the cytoprotective cytokines granulocyte colony‐stimulating factor (G‐CSF) and IL‐6 in mice. Knockdown of G‐CSF and IL‐6 in WJ‐MSCs before injection to lethally irradiated mice or transplantation of WJ‐MSCs to lethally irradiated Nrf‐2 knockout mice significantly nullified the therapeutic protective efficacy. Hence, WJ‐MSCs could be a potential cell‐based therapy for individuals accidentally exposed to radiation. |
